{"id":"W4393385075","doi":"10.1182/blood.2023021620","title":"Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; bluebird bio; Seagen; Gilead Sciences; Leukemia and Lymphoma Society; Celgene; AstraZeneca; TG Therapeutics; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Chemoimmunotherapy; Medicine; Internal medicine; Oncology; Cytokine release syndrome; Lymphoma; Diffuse large B-cell lymphoma; Gastroenterology; Immunotherapy; Rituximab; Cancer; Chimeric antigen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001178244,0.0005056018,0.001166851,0.0003389662,0.000187887,0.0007463301,0.0004572037,0.000765316,0.002662005],"category_scores_gemma":[0.001193232,0.0001708457,0.001593777,0.0003585499,0.0004087673,0.0006224304,0.0003356385,0.001541169,0.0002485162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001065896,"about_ca_system_score_gemma":0.0007316285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001012543,"about_ca_topic_score_gemma":0.00294679,"domain_scores_codex":[0.999443,0.0002781639,0.00003206033,0.00007742181,0.00004953493,0.0001198133],"domain_scores_gemma":[0.9991124,0.0002615185,0.0002222588,0.00005303179,0.00003225535,0.0003184354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9401633,0.006498801,0.007991951,0.0002794624,0.001399531,0.00004410004,0.00003959713,0.0007707584,0.002348376,0.0001116139,0.0008603106,0.03949226],"study_design_scores_gemma":[0.3503127,0.5360078,0.1006282,0.0001546508,0.002855422,0.0002073244,0.0001327373,0.004242917,0.002676017,0.0006846864,0.002045305,0.00005241436],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961284,0.002194257,0.0001043696,0.0001865524,0.00006817816,0.0001728363,0.0003554105,0.00001676791,0.0007731254],"genre_scores_gemma":[0.9980857,0.0004623872,0.0001256615,0.0002178716,0.00007248406,0.0001953571,0.0004572256,0.00000327049,0.0003799978],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002662005,"threshold_uncertainty_score":0.008905292,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005823869615988049,"score_gpt":0.2453510075212674,"score_spread":0.2395271379052794,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}